Image may be NSFW.
Clik here to view.
Clik here to view.
Androxal / Enclomiphene Citrate trials get FDA go ahead.
Repros Therapeutics Inc. said Monday it obtained positive written feedback from the Division of Reproductive and Urologic Products regarding its drug candidate Androxal. In a written advice letter to...
View Article
Image may be NSFW.
Clik here to view.
Clik here to view.
New patent issued for Androxal / Enclomiphene Citrate
Repros Therapeutics Inc. today announced the US Patent and Trademark office has issued U.S. Patent No. 7,759,360 for Androxal(R), the Company’s lead program for the treatment of low testosterone in...
View Article
Image may be NSFW.
Clik here to view.
Clik here to view.
More Pages to Explore .....
